vs
Apple Hospitality REIT, Inc.（APLE）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Apple Hospitality REIT, Inc.的1.9倍（$622.0M vs $326.4M），Royalty Pharma plc净利率更高（34.4% vs 9.1%，领先25.4%），Royalty Pharma plc同比增速更快（4.8% vs -2.0%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -0.5%）
莱曼 hospitality properties是一家深耕酒店、度假村、娱乐及媒体领域的企业，得名于旗下核心资产——位于田纳西州纳什维尔的国家历史地标莱曼礼堂。公司历史可追溯至曾作为爱德华·盖洛德旗下俄克拉荷马出版公司子公司的时期，1983年收购WSM公司后，拿下大奥普里等知名IP，奠定了如今的业务发展基础。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
APLE vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.9倍
$326.4M
营收增速更快
RPRX
高出6.8%
-2.0%
净利率更高
RPRX
高出25.4%
9.1%
两年增速更快
RPRX
近两年复合增速
-0.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $326.4M | $622.0M |
| 净利润 | $29.6M | $214.2M |
| 毛利率 | 37.2% | — |
| 营业利润率 | 15.2% | 62.4% |
| 净利率 | 9.1% | 34.4% |
| 营收同比 | -2.0% | 4.8% |
| 净利润同比 | -0.7% | 2.9% |
| 每股收益（稀释后） | $0.13 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLERPRX
| Q4 25 | $326.4M | $622.0M | ||
| Q3 25 | $373.9M | $609.3M | ||
| Q2 25 | $384.4M | $578.7M | ||
| Q1 25 | $327.7M | $568.2M | ||
| Q4 24 | $333.0M | $593.6M | ||
| Q3 24 | $378.8M | $564.7M | ||
| Q2 24 | $390.1M | $537.3M | ||
| Q1 24 | $329.5M | $568.0M |
净利润APLERPRX
| Q4 25 | $29.6M | $214.2M | ||
| Q3 25 | $50.9M | $288.2M | ||
| Q2 25 | $63.6M | $30.2M | ||
| Q1 25 | $31.2M | $238.3M | ||
| Q4 24 | $29.8M | $208.2M | ||
| Q3 24 | $56.3M | $544.0M | ||
| Q2 24 | $73.9M | $102.0M | ||
| Q1 24 | $54.0M | $4.8M |
毛利率APLERPRX
| Q4 25 | 37.2% | — | ||
| Q3 25 | 40.6% | — | ||
| Q2 25 | 42.6% | — | ||
| Q1 25 | 39.0% | — | ||
| Q4 24 | 38.6% | — | ||
| Q3 24 | 41.9% | — | ||
| Q2 24 | 44.6% | — | ||
| Q1 24 | 40.1% | — |
营业利润率APLERPRX
| Q4 25 | 15.2% | 62.4% | ||
| Q3 25 | 19.4% | 70.1% | ||
| Q2 25 | 22.1% | 36.3% | ||
| Q1 25 | 15.5% | 94.0% | ||
| Q4 24 | 15.0% | 60.9% | ||
| Q3 24 | 20.5% | — | ||
| Q2 24 | 24.0% | 50.2% | ||
| Q1 24 | 21.7% | -13.0% |
净利率APLERPRX
| Q4 25 | 9.1% | 34.4% | ||
| Q3 25 | 13.6% | 47.3% | ||
| Q2 25 | 16.6% | 5.2% | ||
| Q1 25 | 9.5% | 41.9% | ||
| Q4 24 | 9.0% | 35.1% | ||
| Q3 24 | 14.9% | 96.3% | ||
| Q2 24 | 19.0% | 19.0% | ||
| Q1 24 | 16.4% | 0.8% |
每股收益（稀释后）APLERPRX
| Q4 25 | $0.13 | $0.49 | ||
| Q3 25 | $0.21 | $0.67 | ||
| Q2 25 | $0.27 | $0.07 | ||
| Q1 25 | $0.13 | $0.55 | ||
| Q4 24 | $0.13 | $0.46 | ||
| Q3 24 | $0.23 | $1.21 | ||
| Q2 24 | $0.31 | $0.23 | ||
| Q1 24 | $0.22 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.5M | $618.7M |
| 总债务越低越好 | $1.5B | $9.0B |
| 股东权益账面价值 | $3.1B | $9.7B |
| 总资产 | $4.9B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.49× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资APLERPRX
| Q4 25 | $8.5M | $618.7M | ||
| Q3 25 | $50.3M | $938.9M | ||
| Q2 25 | $7.9M | $631.9M | ||
| Q1 25 | $14.9M | $1.1B | ||
| Q4 24 | $10.3M | $929.0M | ||
| Q3 24 | $6.1M | $950.1M | ||
| Q2 24 | $7.2M | $1.8B | ||
| Q1 24 | $4.9M | $843.0M |
总债务APLERPRX
| Q4 25 | $1.5B | $9.0B | ||
| Q3 25 | $1.5B | $8.9B | ||
| Q2 25 | $1.5B | $8.0B | ||
| Q1 25 | $1.5B | $7.6B | ||
| Q4 24 | $1.5B | $7.6B | ||
| Q3 24 | $1.5B | $7.6B | ||
| Q2 24 | $1.5B | $7.6B | ||
| Q1 24 | $1.5B | $6.1B |
股东权益APLERPRX
| Q4 25 | $3.1B | $9.7B | ||
| Q3 25 | $3.2B | $9.6B | ||
| Q2 25 | $3.2B | $9.5B | ||
| Q1 25 | $3.2B | $9.8B | ||
| Q4 24 | $3.3B | $10.3B | ||
| Q3 24 | $3.3B | $10.3B | ||
| Q2 24 | $3.3B | $9.8B | ||
| Q1 24 | $3.3B | $9.9B |
总资产APLERPRX
| Q4 25 | $4.9B | $19.6B | ||
| Q3 25 | $4.9B | $19.3B | ||
| Q2 25 | $4.9B | $18.3B | ||
| Q1 25 | $4.9B | $17.6B | ||
| Q4 24 | $5.0B | $18.2B | ||
| Q3 24 | $5.0B | $18.0B | ||
| Q2 24 | $5.1B | $17.7B | ||
| Q1 24 | $5.0B | $16.1B |
负债/权益比APLERPRX
| Q4 25 | 0.49× | 0.92× | ||
| Q3 25 | 0.47× | 0.93× | ||
| Q2 25 | 0.48× | 0.84× | ||
| Q1 25 | 0.48× | 0.78× | ||
| Q4 24 | 0.45× | 0.74× | ||
| Q3 24 | 0.46× | 0.74× | ||
| Q2 24 | 0.46× | 0.78× | ||
| Q1 24 | 0.45× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $370.2M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $282.0M | — |
| 自由现金流率自由现金流/营收 | 86.4% | — |
| 资本支出强度资本支出/营收 | 27.0% | — |
| 现金转化率经营现金流/净利润 | 12.50× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $516.8M | — |
8季度趋势，按日历期对齐
经营现金流APLERPRX
| Q4 25 | $370.2M | $827.1M | ||
| Q3 25 | $126.4M | $702.6M | ||
| Q2 25 | $108.8M | $364.0M | ||
| Q1 25 | $49.1M | $596.1M | ||
| Q4 24 | $405.4M | $742.5M | ||
| Q3 24 | $128.2M | $703.6M | ||
| Q2 24 | $127.3M | $658.2M | ||
| Q1 24 | $54.7M | $664.6M |
自由现金流APLERPRX
| Q4 25 | $282.0M | — | ||
| Q3 25 | $109.0M | — | ||
| Q2 25 | $96.2M | — | ||
| Q1 25 | $29.5M | — | ||
| Q4 24 | $327.1M | — | ||
| Q3 24 | $113.1M | — | ||
| Q2 24 | $115.0M | — | ||
| Q1 24 | $34.4M | — |
自由现金流率APLERPRX
| Q4 25 | 86.4% | — | ||
| Q3 25 | 29.2% | — | ||
| Q2 25 | 25.0% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 98.2% | — | ||
| Q3 24 | 29.9% | — | ||
| Q2 24 | 29.5% | — | ||
| Q1 24 | 10.4% | — |
资本支出强度APLERPRX
| Q4 25 | 27.0% | — | ||
| Q3 25 | 4.7% | — | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 6.0% | — | ||
| Q4 24 | 23.5% | — | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | 3.2% | — | ||
| Q1 24 | 6.2% | — |
现金转化率APLERPRX
| Q4 25 | 12.50× | 3.86× | ||
| Q3 25 | 2.49× | 2.44× | ||
| Q2 25 | 1.71× | 12.06× | ||
| Q1 25 | 1.57× | 2.50× | ||
| Q4 24 | 13.59× | 3.57× | ||
| Q3 24 | 2.28× | 1.29× | ||
| Q2 24 | 1.72× | 6.45× | ||
| Q1 24 | 1.01× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLE
| Occupancy | $293.0M | 90% |
| Hotel Other | $17.2M | 5% |
| Food And Beverage | $16.3M | 5% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
